Natco Pharma Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO PHARMA USA, and what generic and branded alternatives to NATCO PHARMA USA drugs are available?
NATCO PHARMA USA has seven approved drugs.
Summary for Natco Pharma Usa
| US Patents: | 0 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 7 |
Drugs and US Patents for Natco Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma Usa | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 078827-001 | Oct 26, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Natco Pharma Usa | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 200653-002 | Jun 27, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Natco Pharma Usa | CARBOPLATIN | carboplatin | INJECTABLE;INJECTION | 091510-002 | May 29, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
